Cite

HARVARD Citation

    Schiff, M. et al. (n.d.). AB0480 Certolizumab pegol plus methotrexate is similarly effective in active rheumatoid arthritis regardless of prior TNF inhibitor use: Analysis of the doseflex PHASE IIIB study. Annals of the rheumatic diseases. p. 665. [Online]. 
  
Back to record